Skip to main content

Table 2 Protocol for the treatment of triton induce hyperlipidemia in rats

From: Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait

Group Treatment/route of administration
NC Solvent system (vehicle)
HLC Hyperlipidemic control
FVT-1 Hyperlipidemic + plant extract (FVBM) (50 mg/rat)
FVT-2 Hyperlipidemic + plant extract (FVBM) (100 mg/rat)
CT Hyperlipidemic + bioactive compound (F18) (1 mg/rat)
AT Hyperlipidemic + standard (atorvastatin) (1 mg/rat)